United States Gastroparesis Treatment Market Size, Share, Trends | Growth Forecast 2025 | Major Players 2025 - Conmed Corporation, The Cooper Companies Inc, Teleflex Incorporated

"The global gastroparesis treatment market reached US$ 7.5 billion in 2024 and is expected to reach US$ 11.03 billion by 2033, growing at a CAGR of 4.42% during the forecast period 2025-2033, according to DataM Intelligence research." As per DataM intelligence research report

Download your exclusive sample report today: (corporate email gets priority access): https://www.datamintelligence.com/download-sample/gastroparesis-treatment-market?sp

United States

Recent Launches and Investments

✅ In July 2025, Motus Therapeutics launched a new prokinetic therapy for gastroparesis patients, aiming to improve gastric motility and symptom relief. The therapy targets adults with diabetic and idiopathic gastroparesis. It incorporates advanced drug delivery technology for better efficacy.

✅ In March 2025, Ironwood Pharmaceuticals introduced a novel treatment for gastroparesis with optimized dosing and fewer side effects. The launch included $12 million in R&D investment. It focuses on improving quality of life and patient adherence.

Mergers and Acquisitions

✅ In August 2025, Takeda acquired a U.S.-based biotech company specializing in gastroparesis therapies. The acquisition strengthens Takeda's gastrointestinal portfolio. It supports clinical development and market expansion in North America.

✅ In May 2025, Nestlé Health Science partnered with a startup to co-develop next-generation gastroparesis treatments using innovative drug formulations. The collaboration focuses on efficacy, safety, and patient convenience. It targets hospitals and specialty clinics.

Japan

Recent Launches and Investments

✅ In July 2025, Otsuka Pharmaceutical launched a new gastroparesis therapy for Japanese patients, focusing on improved gastric motility and symptom management. The therapy targets adults with chronic gastroparesis. It aims to enhance treatment adherence and patient outcomes.

✅ In March 2025, Daiichi Sankyo introduced an optimized gastroparesis treatment backed by $8 million in R&D investment. The therapy focuses on fewer side effects and improved efficacy. It supports both hospital and outpatient care in Japan.

Mergers and Acquisitions

✅ In August 2025, Astellas Pharma partnered with a domestic biotech startup to co-develop next-generation gastroparesis therapies. The collaboration strengthens R&D capabilities. It targets innovative treatments and improved patient quality of life.

✅ In May 2025, Takeda Japan acquired a specialty gastroenterology company to expand its gastroparesis treatment portfolio. The acquisition enhances research and manufacturing capabilities. It supports advanced therapies for Japanese patients.

Gastroparesis Treatment Market: Drivers

The gastroparesis treatment market is experiencing steady growth as awareness of gastrointestinal disorders and delayed gastric emptying increases among healthcare providers and patients. Rising prevalence of conditions such as diabetes, which is a major risk factor for gastroparesis, is driving demand for effective therapies to manage symptoms like nausea, vomiting, and bloating. Technological advancements in prokinetic agents, antiemetics, gastric electrical stimulation devices, and novel drug formulations are improving symptom control and patient quality of life. Increasing focus on patient-centric care, early diagnosis, and chronic disease management is further supporting market adoption. With growing emphasis on improving gastrointestinal health and reducing hospitalization, gastroparesis treatments are becoming essential in modern medical care.

Expansion of healthcare infrastructure and increased access to specialty gastroenterology care is creating new opportunities for gastroparesis therapies. Marketing campaigns highlighting symptom relief, improved digestive function, and patient support programs are boosting awareness and adoption among both physicians and patients. Research and development in novel pharmacological agents, combination therapies, and minimally invasive interventions are driving innovation in treatment options. Rising investment in chronic disease management, particularly for diabetes, is further encouraging adoption of gastroparesis treatments. As healthcare systems continue to prioritize digestive health and patient outcomes, the gastroparesis treatment market is poised for sustained growth and innovation.

Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/gastroparesis-treatment-market?sp

Gastroparesis Treatment Market: Major Players

Conmed Corporation, The Cooper Companies Inc, Teleflex Incorporated, Medtronic Plc, B. Braun Medical Inc, JOHNSON & JOHNSON, Laprosurge, Purple Surgical, Shenzhen Mindray Bio-Medical Electronics Co., Ltd. and Peters Surgical among others

Segment Covered in the Gastroparesis Treatment Market:

➥ By Type: Idiopathic Gastroparesis, Diabetic Gastroparesis, Post-Surgical Gastroparesis
➥ By Drug Class: Prokinetic Drugs, Antiemetics, Antidepressants, Liquid Vitamin Supplements, Others
➥ By Route of Administration: Oral, Injectables, Others
➥ By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Research Process:

Both primary and secondary data sources have been used in the Gastroparesis Treatment Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Most Frequently Asked Questions in the Gastroparesis Treatment Market Research Industry:

➠ Who leads the Gastroparesis Treatment industry and what's their competitive positioning regarding capacity, performance, and profitability?
➠ What growth opportunities and market challenges do Gastroparesis Treatment market vendors face?
➠ Which segments show the highest growth potential and market share distribution?
➠ What factors are driving or limiting Gastroparesis Treatment market growth?
➠ What are the dominant sales and distribution strategies in the Gastroparesis Treatment industry?

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=gastroparesis-treatment-market

Regional Analysis:

⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Request for 2 Days FREE Trial Access:
https://www.datamintelligence.com/reports-subscription?sp

✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends

Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.